日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

De Novo Donor-Specific HLA Antibody Formation in Two Patients With Crigler-Najjar Syndrome Type I Following Human Hepatocyte Transplantation With Partial Hepatectomy Preconditioning.

两例 I 型克里格勒-纳贾尔综合征患者在接受部分肝切除术预处理后进行人肝细胞移植,并出现新生供体特异性 HLA 抗体形成

Jorns C, Nowak G, Nemeth A, Zemack H, Mörk L-M, Johansson H, Gramignoli R, Watanabe M, Karadagi A, Alheim M, Hauzenberger D, van Dijk R, Bosma P J, Ebbesen F, Szakos A, Fischler B, Strom S, Ellis E, Ericzon B-G

Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1

剪接位点突变:克里格勒-纳贾尔综合征1型的一种新型遗传机制

Gantla, S; Bakker, C T; Deocharan, B; Thummala, N R; Zweiner, J; Sinaasappel, M; Roy Chowdhury, J; Bosma, P J; Roy Chowdhury, N

Bilirubin glucuronidation by intact Gunn rat fibroblasts expressing bilirubin UDP-glucuronosyltransferase

表达胆红素UDP-葡萄糖醛酸转移酶的完整Gunn大鼠成纤维细胞对胆红素的葡萄糖醛酸化作用

Seppen, J; Tada, K; Hellwig, S; Bakker, C T; Prasad, V R; Roy Chowdhury, N; Roy Chowdhury, J; Bosma, P J; Oude Elferink, R P

Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase

通过突变胆红素尿苷二磷酸葡萄糖醛酸转移酶的表达来区分克里格勒-纳贾尔综合征 I 型和 II 型

Seppen, J; Bosma, P J; Goldhoorn, B G; Bakker, C T; Chowdhury, J R; Chowdhury, N R; Jansen, P L; Oude Elferink, R P